HepaRegenix GmbH


HepaRegeniX GmbH, Advisor: Dr. David Shapiro

Dr. David Shapiro

Dr. David Shapiro has over 30 years of experience in the pharmaceutical and biotechnology industries. Formerly, Dr Shapiro was Chief Medical Officer (CMO) and Head of Research and Development at Intercept Pharmaceuticals from 2007 through 2019. Previously, he was CMO of Idun Pharmaceuticals, acquired by Pfizer in 2005. Before this, Dr. Shapiro was president of the Scripps Medical Research Center of Scripps Clinic and led a highly competitive hypertension clinical research program at MSD Research Laboratories.